Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin McDonnell

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
Journal for Immunotherapy of Cancer|November 2, 2021
BT7480, a novel fully synthetic <i>Bicycle</i> tumor-targeted immune cell agonist™ (<i>Bicycle</i> TICA™) induces tumor localized CD137 agonismKristen Hurov, Johanna Lahdenranta, Punit Upadhyaya, et al.
The American Journal of Pathology|September 28, 2011
Impact of fibroblast growth factor-binding protein-1 expression on angiogenesis and wound healingElena Tassi, Kevin McDonnell, Krissa A Gibby, et al.
Journal for Immunotherapy of Cancer|January 27, 2021
Anticancer immunity induced by a synthetic tumor-targeted CD137 agonistPunit Upadhyaya, Johanna Lahdenranta, Kristen Hurov, et al.
JAMA Network Open|January 13, 2025
Breast Cancer MRI Screening of Patients After Multiplex Gene Panel TestingLeah A Naghi, Julie O Culver, Charité Ricker, et al.
Diabetes Care|November 21, 2018
Variations in Risk of End-Stage Renal Disease and Risk of Mortality in an International Study of Patients With Type 1 Diabetes and Advanced NephropathyJan Skupien, Adam M Smiles, Erkka Valo, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 24, 2017
Hepatic FcRn regulates albumin homeostasis and susceptibility to liver injuryMichal Pyzik, Timo Rath, Timothy T Kuo, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 6, 2015
A Cross-Cancer Genetic Association Analysis of the DNA Repair and DNA Damage Signaling Pathways for Lung, Ovary, Prostate, Breast, and Colorectal CancerPeter M Scarbrough, Rachel Palmieri Weber, Edwin S Iversen, et al.
Translational Behavioral Medicine|February 1, 2018
Patient communication of cancer genetic test results in a diverse populationCharité N Ricker, Rachel B Koff, Chenxu Qu, et al.
Science Translational Medicine|April 12, 2012
Preclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a differentiated pharmacological profileJeffrey Hrkach, Daniel Von Hoff, Mir Mukkaram Ali, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 11, 2026
NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, Pancreatic, and Prostate, Version 2.2026Heather H Cheng, Veda N Giri, Michael Goggins, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Journal for Immunotherapy of Cancer|November 2, 2021
BT7480, a novel fully synthetic <i>Bicycle</i> tumor-targeted immune cell agonist™ (<i>Bicycle</i> TICA™) induces tumor localized CD137 agonismKristen Hurov, Johanna Lahdenranta, Punit Upadhyaya, et al.
The American Journal of Pathology|September 28, 2011
Impact of fibroblast growth factor-binding protein-1 expression on angiogenesis and wound healingElena Tassi, Kevin McDonnell, Krissa A Gibby, et al.
Journal for Immunotherapy of Cancer|January 27, 2021
Anticancer immunity induced by a synthetic tumor-targeted CD137 agonistPunit Upadhyaya, Johanna Lahdenranta, Kristen Hurov, et al.
JAMA Network Open|January 13, 2025
Breast Cancer MRI Screening of Patients After Multiplex Gene Panel TestingLeah A Naghi, Julie O Culver, Charité Ricker, et al.
Diabetes Care|November 21, 2018
Variations in Risk of End-Stage Renal Disease and Risk of Mortality in an International Study of Patients With Type 1 Diabetes and Advanced NephropathyJan Skupien, Adam M Smiles, Erkka Valo, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 24, 2017
Hepatic FcRn regulates albumin homeostasis and susceptibility to liver injuryMichal Pyzik, Timo Rath, Timothy T Kuo, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 6, 2015
A Cross-Cancer Genetic Association Analysis of the DNA Repair and DNA Damage Signaling Pathways for Lung, Ovary, Prostate, Breast, and Colorectal CancerPeter M Scarbrough, Rachel Palmieri Weber, Edwin S Iversen, et al.
Translational Behavioral Medicine|February 1, 2018
Patient communication of cancer genetic test results in a diverse populationCharité N Ricker, Rachel B Koff, Chenxu Qu, et al.
Science Translational Medicine|April 12, 2012
Preclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a differentiated pharmacological profileJeffrey Hrkach, Daniel Von Hoff, Mir Mukkaram Ali, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 11, 2026
NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, Pancreatic, and Prostate, Version 2.2026Heather H Cheng, Veda N Giri, Michael Goggins, et al.
Pageof 6